• Source: The Cooper Companies

      • The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's health care market.


      History


      CooperCompanies was founded in 1958 as Martin H. Smith Co. and in 1961, incorporated as Cooper Tinsley Laboratories Inc. The company changed its name to Cooper Laboratories Inc. in 1967, and entered the contact lens business when it acquired British lens maker GlobalVision in 1972.
      In 1980, Cooper Laboratories reorganized into three business groups: CooperVision, CooperCare and CooperBiomedical, with Cooper Medical Devices Corp. added as a fourth group one year later.
      The company was renamed The Cooper Companies in 1987. Three years later, it was further restructured into three business units: CooperVision, CooperSurgical and CooperVision Pharmaceuticals (dissolved in 2003).
      Currently, the firm operates as two business units: CooperVision and CooperSurgical. CooperVision serves contact lens wearers and eye care practitioners. Products include a range of daily, two-week and monthly disposable contact lenses, and other spherical, toric and multifocal lenses for astigmatism, nearsightedness and farsightedness, and presbyopia. In 2022, CooperVision acquired EnsEyers, a supplier of orthokeratology and scleral contact lenses.
      CooperSurgical is the medical device and fertility and genomics unit of the companies. It became a business unit in 1990 and its focus includes women's health and fertility.
      Albert G. White III was named president and CEO in May 2018. Holly Sheffield was named President of CooperSurgical effective July 2020. In February 2021, CooperSurgical acquired AEGEA Medical, a medical manufacturing company. In March 2021, the company acquired Safe Obstetric Systems. In December 2021, CooperSurgical acquired Generate Life Sciences for $1.6 billion.
      In March 2022, CooperSurgical acquired Cook Medical's reproductive health business for $875 million.


      See also


      List of S&P 400 companies


      References




      External links


      Business data for The Cooper Companies, Inc.:

    Kata Kunci Pencarian: